Significance of CD71 expression by flow cytometry in diagnosis of acute leukemia

References

• Glasova M, Konikova E, Stasakova J, et al. The relationship of HLA-DR, CD38 and CD71 markers to activation, proliferation and differentiation of some human leukemia and lymphoma cells. Neoplasma 1998;45:88–95.
   PubMed Web of Science ®Google Scholar
• Testa U, Pelosi E, Peschle C. The transferrin receptor. Crit Rev Oncog 1993;4:241–276.
   PubMed Web of Science ®Google Scholar
• Caruso A, Licenziati S, Corulli M, et al. Flow cytometric analysis of activation markers on stimulated T cells and their correlation with cell proliferation. Cytometry 1997;27:71–76.
   PubMedGoogle Scholar
• Damle RN, Ghiotto F, Valetto A, et al. B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. Blood 2002;99:4087–4093.
   PubMed Web of Science ®Google Scholar
• O’Donnell KA, Yu D, Zeller KI, et al. Activation of transferrin receptor 1 by c-Myc enhances cellular proliferation and tumorigenesis. Mol Cell Biol 2006;26:2373–2386.
   PubMed Web of Science ®Google Scholar
• Schaar DG, Medina DJ, Moore DF, et al. miR-320 targets transferrin receptor 1 (CD71) and inhibits cell proliferation. Exp Hematol 2009;37:245–255.
   PubMed Web of Science ®Google Scholar
• Beguin Y. Soluble transferrin receptor for the evaluation of erythropoiesis and iron status. Clin Chim Acta 2003;329:9–22.
   PubMed Web of Science ®Google Scholar
• Mihova D, Zhang L. Acute erythroid leukemia: a review. N Am J Med Sci 2012;5:110–118.
   Google Scholar
• Wood BL. Myeloid malignancies: myelodysplastic syndromes, myeloproliferative disorders, and acute myeloid leukemia. Clin Lab Med 2007;27:551–575.
   PubMed Web of Science ®Google Scholar
• Sharma A, Buxi G, Walia R, et al. Childhood acute erythroleukemia diagnosis by flow cytometry. Indian J Pathol Microbiol 2011;54: 173–175.
   PubMed Web of Science ®Google Scholar
• Domingo-Claros A, Larriba I, Rozman M, et al. Acute erythroid neoplastic proliferations. A biological study based on 62 patients. Haematologica 2002;87:148–153.
   PubMed Web of Science ®Google Scholar
• Davis BH, Holden JT, Bene MC, et al. 2006 Bethesda International Consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia: medical indications. Cytometry B Clin Cytom 2007;72(Suppl. 1):S5–S13.
   PubMed Web of Science ®Google Scholar
• Braylan RC, Orfao A, Borowitz MJ, et al. Optimal number of reagents required to evaluate hematolymphoid neoplasias: results of an international consensus meeting. Cytometry 2001;46:23–27.
   PubMedGoogle Scholar
• Dong HY, Wilkes S, Yang H. CD71 is selectively and ubiquitously expressed at high levels in erythroid precursors of all maturation stages: a comparative immunochemical study with glycophorin A and hemoglobin A. Am J Surg Pathol 2011;35:723–732.
   PubMed Web of Science ®Google Scholar
• Marsee DK, Pinkus GS, Yu H. CD71 (transferrin receptor) an effective marker for erythroid precursors in bone marrow biopsy specimens. Am J Clin Pathol 2010;134:429–435.
   PubMed Web of Science ®Google Scholar
• Borowitz M, Bene MC, Harris NL, et al. Acute leukemias of ambiguous lineage. In: Swerdlow SH, Campo E, Harris NL, et al., editors. World Health Organization classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon; IARC Press; 2008. p150–155.
   Google Scholar
• Fialkow PJ, Singer JW, Adamson JW, et al. Acute nonlymphocytic eukemia: heterogeneity of stem cell origin. Blood 1981;57:1068–1073.
   PubMed Web of Science ®Google Scholar
• Turhan A, Lemoine F, Debert C, et al. Highly purified primitive hematopoietic stem cells are PML-RARA negative and generate nonclonal progenitors in acute promyelocytic leukemia. Blood 1995; 85:2154–2161.
   PubMed Web of Science ®Google Scholar
• Ferraris AM, Broccia G, Meloni T, et al. Clonal origin of cells restricted to monocytic differentiation in acute nonlymphocytic leukemia. Blood 1984;64:817–820.
   PubMed Web of Science ®Google Scholar
• Bender JG, Unverzagt KL, Walker DE, et al. Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry. Blood 1991;77:2591–2596.
   PubMed Web of Science ®Google Scholar
• Loken MR, Shah VO, Dattilio KL, et al. Flow cytometric analysis of human bone marrow: I. Normal erythroid development. Blood 1987;69:255–263.
   PubMed Web of Science ®Google Scholar
• Malcovati L, Della Porta M, Lunghi M, et al. Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome. Leukemia 2005;19:776–783.
   PubMed Web of Science ®Google Scholar
• Della Porta M, Malcovati L, Invernizzi R, et al. Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome. Leukemia 2006;20:549–555.
   PubMed Web of Science ®Google Scholar
• Park S, Picard F, Dreyfus F. Erythroleukemia: a need for a new definition. Leukemia 2002;16:1399–1401.
   PubMed Web of Science ®Google Scholar
• Goldfarb AN, Wong D, Racke FK. Induction of megakaryocytic differentiation in primary human erythroblasts: a physiological basis for leukemic lineage plasticity. Am J Pathol 2001;158:1191–1198.
   PubMed Web of Science ®Google Scholar
• Rieger MA, Smejkal BM, Schroeder T. Improved prospective identification of megakaryocyte–erythrocyte progenitor cells. Br J Haematol 2009;144:448–451.
   PubMed Web of Science ®Google Scholar
• Ito E, Kasai M, Toki T, et al. Expression of erythroid-specific genes in megakaryoblastic disorders. Leuk Lymphoma 1996;23: 545–550.
   PubMed Web of Science ®Google Scholar
• Karandikar NJ, Aquino DB, McKenna RW, et al. Transient myeloproliferative disorder and acute myeloid leukemia in Down syndrome. Am J Clin Pathol 2001;116:204–210.
   PubMed Web of Science ®Google Scholar
• Koehler M, Behm F, Hancock M, et al. Expression of activation antigens CD38 and CD71 is not clinically important in childhood acute lymphoblastic leukemia. Leukemia 1993;7:41–45.
   PubMed Web of Science ®Google Scholar
• Płoszyńska A, Ruckemann-Dziurdzińska K, Jóźwik A, et al. Cytometric evaluation of transferrin receptor 1 (CD71) in childhood acute lymphoblastic leukemia. Folia Histochem Cytobiol 2012;50 :304–311.
   PubMed Web of Science ®Google Scholar
• Jan M, Majeti R. Clonal evolution of acute leukemia genomes. Oncogene 2013;32:135–140.
   PubMed Web of Science ®Google Scholar
• Chen X, Wang G, Xing H, et al. Changes of cell immunophenotypes after transformation from myeloproliferative disorders into acute myeloid leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2012;20: 636–641.
   PubMedGoogle Scholar
• Westfall DE, Zhang L, Song S, et al. Concurrent megakaryocytic and erythroid chronic myelogenous leukemia blast crisis. Arch Pathol Lab Med 2008;132:1021–1025.
   PubMed Web of Science ®Google Scholar
• Hou Y, Song L, Zhu P, et al. Single-cell exome sequencing and monoclonal evolution of a JAK2-negative myeloproliferative neoplasm. Cell 2012;148:873–885.
   PubMed Web of Science ®Google Scholar